Association of C-reactive protein and HIV infection with acute myocardial infarction - PubMed (original) (raw)
Association of C-reactive protein and HIV infection with acute myocardial infarction
Virginia A Triant et al. J Acquir Immune Defic Syndr. 2009.
Abstract
Objective: To investigate whether elevated C-reactive protein (CRP) levels and HIV infection are independently associated with acute myocardial infarction (AMI) among patients receiving care in a large US health care system.
Methods: Analyses included patients receiving care in the Partners HealthCare System between January 1997 and December 2006, with a most recent CRP less than 3 years and more than 1 week before AMI. Over this period, 70,357 (487 HIV and 69,870 non-HIV) patients met these criteria, from the background population of 1,648,687 patients followed in the system. We included both CRP and high-sensitivity CRP and defined elevated CRP based on the normal range of the assay used. We used multivariate logistic regression analysis to test the association of elevated CRP and HIV with AMI after adjustment for demographic and other cardiovascular covariates, including hypertension, diabetes, and dyslipidemia.
Results: In univariate analyses, elevated CRP and HIV were each significantly associated with AMI [odds ratio (OR) 2.51; 95% confidence interval (CI) 2.27 to 2.78; P < 0.0001 for elevated CRP and OR 2.07; 95% CI 1.31 to 3.10; P = 0.001 for HIV]. In a combined model including CRP category and HIV status, elevated CRP (OR 2.50; 95% CI 2.26 to 2.77; P < 0.0001) and HIV (OR 1.74; 95% CI 1.10 to 2.61; P = 0.01) were both independently associated with AMI. In a fully adjusted model controlling for age, sex, race, hypertension, diabetes, and dyslipidemia, both elevated CRP (OR 2.13; 95% CI 1.92 to 2.37; P < 0.0001) and HIV (OR 1.93; 95% CI 1.21 to 2.93; P = 0.004) remained independently associated with AMI. Compared with patients with normal CRP and without HIV, the OR for AMI was increased more than 4-fold among patients with HIV and elevated CRP.
Conclusions: Elevated CRP and HIV are independently associated with increased AMI risk, and patients with HIV with increased CRP have a markedly increased relative risk of AMI. Measurement of CRP may be useful in the cardiovascular risk assessment of patients with HIV.
Figures
FIGURE 1
Study sample. The initial query generated 1,648,687 patients. Of these, 77,835 had CRP test data available during the study period from Brigham and Women's Hospital or Massachusetts General Hospital. After excluding patients whose most recent CRP value was after the first AMI, less than 1 week before the first AMI, or more than 3 years before the first AMI, there were 70,357 patients. Of these patients, 487 were HIV infected and 69,870 were not HIV infected. The distribution of normal vs. elevated CRP is shown in the Figure.
Similar articles
- Prevalence and predictors of elevated high-sensitivity C-reactive protein in post-myocardial infarction patients: Insights from the VIRGO and TRIUMPH registries.
Qintar M, Sharma PP, Pokharel Y, Tang Y, Lu Y, Jones P, Dreyer RP, Spertus JA. Qintar M, et al. Clin Cardiol. 2017 Dec;40(12):1205-1211. doi: 10.1002/clc.22816. Epub 2017 Dec 16. Clin Cardiol. 2017. PMID: 29247528 Free PMC article. - Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.
Triant VA, Lee H, Hadigan C, Grinspoon SK. Triant VA, et al. J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12. doi: 10.1210/jc.2006-2190. Epub 2007 Apr 24. J Clin Endocrinol Metab. 2007. PMID: 17456578 Free PMC article. - Sex Differences in Inflammatory Markers and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients) Study.
Lu Y, Zhou S, Dreyer RP, Spatz ES, Geda M, Lorenze NP, D'Onofrio G, Lichtman JH, Spertus JA, Ridker PM, Krumholz HM. Lu Y, et al. Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2):e003470. doi: 10.1161/CIRCOUTCOMES.116.003470. Epub 2017 Feb 22. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28228461 Free PMC article. - High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
Pokharel Y, Sharma PP, Qintar M, Lu Y, Tang Y, Jones P, Dreyer RP, Spertus JA. Pokharel Y, et al. Atherosclerosis. 2017 Nov;266:16-23. doi: 10.1016/j.atherosclerosis.2017.09.019. Epub 2017 Sep 18. Atherosclerosis. 2017. PMID: 28946036 Free PMC article.
Cited by
- Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection.
Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS. Kelesidis T, et al. AIDS. 2016 Nov 13;30(17):2625-2633. doi: 10.1097/QAD.0000000000001238. AIDS. 2016. PMID: 27603288 Free PMC article. - HIV infection and older Americans: the public health perspective.
Brooks JT, Buchacz K, Gebo KA, Mermin J. Brooks JT, et al. Am J Public Health. 2012 Aug;102(8):1516-26. doi: 10.2105/AJPH.2012.300844. Epub 2012 Jun 14. Am J Public Health. 2012. PMID: 22698038 Free PMC article. Review. - Role of Autophagy in HIV-1 and Drug Abuse-Mediated Neuroinflammaging.
Sil S, Thangaraj A, Oladapo A, Hu G, Kutchy NA, Liao K, Buch S, Periyasamy P. Sil S, et al. Viruses. 2022 Dec 23;15(1):44. doi: 10.3390/v15010044. Viruses. 2022. PMID: 36680084 Free PMC article. Review. - Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women.
Cedarbaum E, Ma Y, Scherzer R, Price JC, Adimora AA, Bamman M, Cohen M, Fischl MA, Matsushita K, Ofotokun I, Plankey M, Seaberg EC, Yin MT, Grunfeld C, Vartanian S, Sharma A, Tien PC. Cedarbaum E, et al. AIDS. 2019 Nov 1;33(13):2025-2033. doi: 10.1097/QAD.0000000000002319. AIDS. 2019. PMID: 31335806 Free PMC article. - Cardiac Steatosis in HIV-A Marker or Mediator of Disease?
Jacob M, Holloway CJ. Jacob M, et al. Front Endocrinol (Lausanne). 2018 Oct 11;9:529. doi: 10.3389/fendo.2018.00529. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30364255 Free PMC article. Review.
References
- Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003;33:506–512. - PubMed
- Klein D, Hurley LB, Quesenberry CP, Jr, et al. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr. 2002;30:471–477. - PubMed
- Klein D, Hurley L, Silverberg M, et al. Surveillance data for myocardial infarction hospitalizations among HIV+ and HIV- Northern Californians: 1994–2006. Paper presented at: 14th Conference on Retroviruses and Opportunistic Infections; February 27, 2007; Los Angeles, CA.
- Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165:1179–1184. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32 AI007387/AI/NIAID NIH HHS/United States
- K01 AI073109/AI/NIAID NIH HHS/United States
- K24 DK080140/DK/NIDDK NIH HHS/United States
- K01 AI073109-01A1/AI/NIAID NIH HHS/United States
- K24 DK064545/DK/NIDDK NIH HHS/United States
- T32 AI07387/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous